10.70
0.00
(0.00%)
As of 8:08:40 AM GMT+2. Market Open.
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | -- | -- | 15.25M | 14.25M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 30.5M | 28.5M |
| Year Ago Sales | -- | -- | 3.33M | 15.25M |
| Sales Growth (year/est) | -- | -- | 357.96% | -6.56% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0VQ0.F | -- | -- | -- | -- |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight | 8/25/2022 |
| Maintains | SVB Leerink: Outperform | 8/9/2022 |
| Maintains | SVB Leerink: Outperform | 6/15/2022 |
| Maintains | SVB Leerink: Outperform | 1/7/2022 |
| Maintains | SVB Leerink: Outperform | 8/25/2021 |
| Initiated | SVB Leerink: Outperform | 1/15/2021 |
Related Tickers
CGON CG Oncology, Inc.
18.55
+5.19%
NAMS NewAmsterdam Pharma Company N.V.
15.00
+0.67%
STOK Stoke Therapeutics, Inc.
6.99
+7.21%
ASND Ascendis Pharma A/S
150.40
+4.93%
SRRK Scholar Rock Holding Corporation
27.55
+4.71%
TERN Terns Pharmaceuticals, Inc.
2.1250
-0.70%
ARVN Arvinas, Inc.
6.90
+4.23%
SWTX SpringWorks Therapeutics, Inc.
35.43
+2.90%
APLS Apellis Pharmaceuticals, Inc.
19.08
+1.52%
CAPR Capricor Therapeutics, Inc.
9.33
+5.07%